SHANNEL MILLARD: Open Payments
NPI 1326404245 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 49 payments from 16 companies in 2025. Trend: 2023 $663 · 2024 $887 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $229 |
| Dexcom, Inc. | 4 | $85 |
| ABBVIE INC. | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Novo Nordisk Inc | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Dynavax Technologies Corporation | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Melinta Therapeutics, LLC | 2 | $31 |
Products named: PREVNAR 20, NURTEC ODT, CAPLYTA, Dexcom G6 Transmitter, BEXSERO, VRAYLAR, ZERBAXA, Heplisav-B.
Industry payments across KS — which companies pay providers there.
